Agilent | A - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 299M 231M 2026-06
Agilent USD 29M 4M 2026-06
Align Technology USD 6.93M 9.11M 2026-03
Bio Techne USD 3.6M 1.19M 2026-06
Bio-Rad Laboratories USD 12.1M 200K 2026-06
Bruker USD 17.8M 9.7M 2026-06
Charles River Laboratories USD 30.34M 3.6M 2026-06
Danaher USD 107M 44M 2026-06
Dentsply International USD 22M 2M 2026-06
Edwards Lifesciences USD 30M 5.9M 2026-06
Henry Schein USD 43M 4M 2026-06
Illumina USD 24M 2M 2026-03
Intuitive Surgical USD 20.88B 765.6M 2026-06
IQVIA Holdings USD 197M 5M 2026-06
Laboratory Of America USD 61.1M 6M 2026-06
Mettler Toledo International USD 17.25M 239K 2026-06
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Quidel USD 5.63B 5.58B 2026-03
Repligen USD 5.66M 85K 2026-06
Revvity USD 22.99M 1.73M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Thermo Fisher Scientific USD 354M 11M 2026-03
Waters USD 55M 13M 2026-06
Zimmer Biomet Holdings USD 22.8B 22.73B 2026-06